-Economic and Political Weekly Corruption in Indian medicine is back on the front pages. One would think that there has been an abrupt spurt in corrupt practices or a major scandal. Nothing of that sort has happened. However, there have been some interesting developments for the focus to shift back to what is really a very old affliction. This is an update on recent happenings as the entrepreneurial spirit of the...
More »SEARCH RESULT
Total Matching Records found : 17
Fight against healthcare graft to focus on India -Rema Nagarajan
-The Times of India NEW DELHI: British Medical Journal (BMJ) has announced the launch of a campaign against corruption in medicine, which will begin with its focus on India. The journal urged people to join its international fight back against kickbacks. The editorial in BMJ regarding the campaign stated that corruption in healthcare was a complex challenge that medical professionals have failed to deal with, either by choosing to enrich themselves,...
More »AIIMS doctors lead the way, wage war on unnecessary medical tests -Rema Nagarajan
-The Times of India NEW DELHI: Top cardiologists of the All India Institute of Medical Sciences (AIIMS) here have decided to start an initiative called the Society for Less Investigative Medicine (SLIM) - a movement that aims to take on the growing menace of excessive medical investigations, starting with cardiology. Several studies across the world have conclusively established that generalized annual health check-ups are unnecessary and add enormously to healthcare costs without...
More »BMJ article on graft in Indian healthcare creates stir
-The Indian Express The article has seen response in the form of an editorial by a noted doctor in India, and a campaign against corruption in healthcare by BMJ that will start with a focus on India. A British Medical Journal (BMJ) article on corruption in Indian healthcare is creating a flutter in the medical community and policy experts. Written by Australian medical practitioner Dr David Berger who volunteered as a...
More »Rx: Make All Clinical Trial Data Public
-The Economic Times Should drug companies make clinical trials data public? All over the world, drug regulators are increasingly in favour of doing so, much to the discomfort of pharmaceutical companies, and the London-based European Medicines Agency (EMA) is the first mover in this regard. As the journal Nature reports, EMA is likely to do so by next year, at least for some clinical trials data. On April 19, all the...
More »
